ReviewBJPsych open2026

The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials.

Mike Trott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.